drug

rifaximin

1 story · latest Jul 29, 2026

Status: FDA approved May 2004 · NDA021361, NDA022554
Brand: Xifaxan

Relationships

Developed by Bausch Health Companies Inc.

Timeline

Bausch Health raises 2026 guidance after second-quarter revenue climbs 13%

Jul 29Quarterly updateBausch Health Companies Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.